|
|
 |
|
Viewing report
|
|
|
|
Chinese Markets for Leukemia Treatment Drugs
AMID Co., June 2009, Pages: 262
Chinas demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines Chinas economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through to 2013 and 2018 are presented. Major producers in China are profiled.
Customers who bought this item also bought
Drugs of Tomorrow: Leukemia - Chemopotentiators Will Drive Growth in the Acute Leukemia Markets
Chronic Myelogenous Leukemia: New Targeted Therapies Take Aim at Gleevec
Analytical Tool - Leukemia Therapeutics & Competitive Insights
Leukemia - A Therapeutic & Competitive Insight
Acute Myeloid Leukemia: Cytarabine Here to Stay
Chinese Markets for Blood Disease Drugs
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma
Drugs of Tomorrow: Cancer Overview
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer
Niche Cancers 2001: Acute Myeloid Leukemia
Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies
Stakeholder Insight: Supportive Care in Cancer Treatment - Some First-Generation Products Proving Difficult to Dislodge
|
|
|
|
